health
HER2-positive in 7.7% of screened ESCC cases in Danish study
A Danish nationwide screening effort found conventional HER2-positive status in 62 of 806 people with esophageal squamous cell carcinoma. In a small phase II trial, trastuzumab-based treatment showed responses, while tissue mapping found HER2-poor fibrotic areas enriched for B7-H3.